Northwire Canada EditionFriday, July 17, 2026
Northwire
LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8%
Financings

Aduro Clean Technologies Announces Pricing of US$20 Million Underwritten Public Offering

ACT · Price

Executive Summary

  • Aduro Clean Technologies priced an underwritten U.S. public offering of 1,739,130 common shares with accompanying warrants, generating gross proceeds of approximately US$20 million.
  • The offering includes a half‑warrant structure (exercise price US$16.00) and grants the lead underwriter a 45‑day over‑allotment option for up to an additional 260,869 shares (or related warrants).
  • Net proceeds are earmarked primarily for construction of the company’s Demonstration‑Scale Plant, with any remainder allocated to R&D, general corporate purposes, and working capital.

Key Details

  • Securities Offered:
  • 1,739,130 common shares
  • Warrants to purchase 869,565 common shares (half‑warrant; each whole warrant = one share)
  • Pricing & Proceeds:
  • Gross proceeds ≈ US$20 million before underwriting discounts and expenses.
  • Warrant Terms:
  • Exercise price: US$16.00 per share
  • Exercisable immediately upon issuance
  • Expiration: 3 years from issuance date
  • Underwriters & Advisors:
  • Lead underwriter: D. Boral Capital LLC
  • Financial advisor: Roth Capital Partners
  • Over‑Allotment Option:
  • Up to 260,869 additional common shares and/or warrants for 130,434 additional common shares may be purchased within a 45‑day period.
  • Closing Timeline:
  • Expected closing on or about December 22, 2025, subject to customary conditions.
  • Regulatory Filings:
  • Offering made under an effective shelf registration statement (Form F‑10, File No. 333‑292023) filed December 15, 2025.
  • Canadian short‑form base shelf prospectus dated December 15, 2025 also referenced.
  • Use of Proceeds:
  • Primary: Construction of the Demonstration‑Scale Plant.
  • Secondary (if any funds remain): Ongoing research & development, general corporate purposes, and working capital.

Notable Quotes

(No executive quotes were included in the release.)

Read the original news release →

More from Aduro Clean Technologies Inc.